Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer-Reference-Cited by-同舟云学术

Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer

Published:2006-02 Issue:2 Volume:67 Page:349-353
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Rossi Peter J.,Clark Peter E.,Papagikos Michael A.,McCullough David L.,Lee W. Robert

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. Cancer statistics, 2005;Jemal;CA Cancer J Clin,2005

2. The changing face of low-risk prostate cancer;Cooperberg;J Clin Oncol,2004

3. The National Cancer Database Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S;Mettlin;Cancer,1999

4. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;JAMA,1998

5. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer;D’Amico;J Clin Oncol,2000

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognosis of patients with prostate cancer receiving permanent seed implantation stratified by prostate volume: Should we be reluctant to treat with brachytherapy because of a very small prostate (<15 cc)?;Radiotherapy and Oncology;2023-11

2. Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men;Scientific Reports;2023-05-23

3. Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival;Journal of Contemporary Brachytherapy;2021

4. Neoplasms of the Prostate;Urologic Surgical Pathology;2020

5. Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers;Radiation Oncology;2019-12-31